@article{article, title  = {{549 - Laboratory parameters in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{http://dx.doi.org/10.1093/bjd/ljad498.049 }},

 year = {{2024}},

 month = {{2}},

 author = {{Paller A and Cork M and Hong C-H and Soong W and Schneider S and Lo H and Pedersen LRM and Vacko E and Wollenberg A}},

 doi = {{10.1093/bjd/ljad498.049}},

 volume = {{190}},

 journal = {{British Journal of Dermatology}},

 issue = {{Supplement_2}},

 pages = {{ii47-ii48}},

 note = {{Accessed on 2024/12/22}}}